Monday, March 26, 2012

Diagnosis and Drug Development for Alzheimer's Disease

Please Help Support Alzheimer's Research Today! 
Your Alzheimer's donation will help billions live without it.

( robust and reliable novel biomarker candidates )
Alzheimer's disease is characterized by aggregates in the brain, containing a protein called beta-amyloid. The neuropathology of Alzheimer's disease has recently been linked to the neurotoxic amyloid-β (Aβ) oligomers. The crucial role of Aβ oligomers in the early events of AD is experimentally underlined. Several recent results suggest that those oligomers may cause the death of neurons and neurological dysfunctions relevant to memory. Furthermore Aβ oligomers levels are increased in brain and cerebrospinal fluid samples from people with Alzheimer's disease. This reflects the potential of Aβ oligomers as a marker for the early diagnosis of the disease.
An international team of scientists from Germany, Sweden and the U.S. have used a new method to quantify soluble variants of aggregated beta-amyloid (Aβ oligomers) in cerebrospinal fluid by flow cytometry. "We found that patients with a greater number of Aβ oligomers in the cerebrospinal fluid had a more pronounced disease," says Dr. Alexander Navarrete Santos (the developer of this method and now employee of the Research Laboratory of the University of Halle, Department of Cardiothoracic Surgery), and first author of the study. Continue to readsciencedaily.com


Read more here: http://www.bnd.com/2012/02/07/2047945/obama-to-seek-more-alzheimers.html#storylink=cpy

Curcumin may have Parkinson's promise

Intake of the tumeric spice curcumin could help to reduce clumping of proteins associated with the onset of Parkinson’s disease, according to new research. Read morenutraingredients.com

Get Energy Active!
Погода в Беларуси

Posted YVN (AMYLOID @ PHOTO). 

No comments:

Post a Comment